Trontinemab, utilizing Roche’s Brainshuttle technology, boosts drug delivery across the blood-brain barrier, driving robust plaque reduction with low ARIA rates.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/trontinemab-rapidly-clears-amyloid-less-aria-2025a1000xzj?src=rss
Author :
Publish date : 2025-12-04 11:52:00
Copyright for syndicated content belongs to the linked Source.